Key points are not available for this paper at this time.
These results illustrate the potential versatility of eravacycline with a broad activity spectrum, good safety and tolerability profile, flexibility for use in patients with renal injury or antibiotic allergies, and positive clinical outcomes in this real-world cohort.
Hobbs et al. (Sun,) studied this question.